$KalVista Pharmaceuticals, Inc.(KALV)$ 8-K - Current report Filed: 2017-07-13 AccNo: 0001193125-17-227682 Size: 257 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接